Year |
Citation |
Score |
2016 |
Starke I, Johnson KM, Petersen J, Gräber P, Opipari AW, Glick GD, Börsch M. Binding of the immunomodulatory drug Bz-423 to mitochondrial F0F1-ATP synthase in living cells by FRET acceptor photobleaching Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9712. DOI: 10.1117/12.2209645 |
0.644 |
|
2009 |
Johnson KM, Swenson L, Opipari AW, Reuter R, Zarrabi N, Fierke CA, Börsch M, Glick GD. Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin. Biopolymers. 91: 830-40. PMID 19462418 DOI: 10.1002/Bip.21262 |
0.694 |
|
2007 |
Cleary J, Johnson KM, Opipari AW, Glick GD. Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorganic & Medicinal Chemistry Letters. 17: 1667-70. PMID 17251020 DOI: 10.1016/J.Bmcl.2006.12.102 |
0.704 |
|
2006 |
Johnson KM, Cleary J, Fierke CA, Opipari AW, Glick GD. Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase. Acs Chemical Biology. 1: 304-8. PMID 17163759 DOI: 10.1021/Cb600143J |
0.735 |
|
2005 |
Johnson KM, Chen X, Boitano A, Swenson L, Opipari AW, Glick GD. Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chemistry & Biology. 12: 485-96. PMID 15850986 DOI: 10.1016/J.Chembiol.2005.02.012 |
0.726 |
|
2002 |
Blatt NB, Bednarski JJ, Warner RE, Leonetti F, Johnson KM, Boitano A, Yung R, Richardson BC, Johnson KJ, Ellman JA, Opipari AW, Glick GD. Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. The Journal of Clinical Investigation. 110: 1123-32. PMID 12393848 DOI: 10.1172/Jci16029 |
0.555 |
|
Show low-probability matches. |